Back

Development of synthetic T2 parametric maps using OS-CMR and novel residual gans (RGAN) for myocardial edema detection

11 December 2025 (09:30 - 10:15)
Organised by: Logo
Congress Presentation Part of: Cardiovascular magnetic resonance in specific cohorts T1 and T2 Mapping EACVI Premium Access EACVI 2025 European Association of Cardiovascular Imaging (EACVI)

About the speaker

Photo
Doctor Mitchel Benovoy

(Canada)

6 More presentations in this session

Presentation thumbnail
Long-axis myocardial strain assessment from cardiovascular magnetic resonance feature tracking in the German National Cohort (NAKO)
Professor J. Schulz-Menger (Berlin, DE) Doctor J. Groeschel (Berlin, DE)
Abstract Slides
Presentation thumbnail
Unravelling early myocardial changes in rheumatoid arthritis by cardiovascular magnetic resonance: insights from the UK biobank
Doctor T. Nyi (London, GB)
Abstract Slides
Presentation thumbnail
Changes in CMR-derived global longitudinal strain, progression of fibrosis and outcome in hypertrophic cardiomyopathy
Doctor A. Barison (Pisa, IT)
Slides
Presentation thumbnail
CMR-derived global dispersion score predicts long-term outcomes after STEMI: insights from the 15-year follow-up of the MUSTELA RCT
Doctor L. Fulceri (Pisa, IT)
Abstract Slides
Presentation thumbnail
CMR risk prediction of ventricular arrhythmic events in excessive trabeculation of the left ventricle
Mr S. del Fresno Perez (Barcelona, ES)
Abstract Slides

Access the full session

Session thumbnail
Cardiovascular magnetic resonance in specific cohorts

The Event

Event poster

EACVI 2025

11 December 2025 09:30 CET
You may be interested in
thumbnail
Congress Presentation
T1-mapping inversion times of the infarcted myocardium and long term cardiovascular outcomes in St-elevation myocardial infarction.
thumbnail
Congress Presentation
Cardiac magnetic resonance imaging for the diagnosis of cardiac amyloidosis in patients with heart failure
thumbnail
Congress Presentation
Use of CMR in the assessment of cardiovascular reserve in patients treated with CAR-T therapy

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources